Over the course of a decade, Freyr has dramatically expanded its Regulatory offerings across all the business segments, such as Pharmaceuticals, Biologics / Vaccines, Generics, Medical Devices, Consumer Healthcare, Cosmetics, Food and Food Supplements, Chemicals, etc. Started as a technology service provider, Freyr eventually forayed into multiple Regulatory offerings ranging from consulting, outsourcing, digital, staffing, including end-to-end Regulatory lifecycle product ownership services. Freyr has set up dedicated Centers of Excellence (CoE) across the entire Regulatory value-chain, including ancillary functions like Pharmacovigilance, and each of these CoEs have grown from strength-to-strength over the past decade.
Freyr has grown to be a trusted Regulatory partner to 950+ global customers, including 8 of the Global Top 10 Drugs and Biotechnology Companies, 4 of the Top 10 Med Tech and Healthcare Equipment and services companies, 2 of the Global Leading COVID Vaccine companies, 4 of the Global Top 10 Household & Personal Products Companies, and 2 of the Top 10 Food & Drinks Companies, and 100s of Mid-market $1+ Billion BioPharma, and Several Small and Medium, Fast Growing Life Sciences companies, CROs, and Standards Agencies.
###